Dr. Manmeet Ahluwalia, MD
Claim this profileMiami Cancer Institute at Baptist Health, Inc.
Studies Brain Cancer
Studies Brain Tumor
8 reported clinical trials
15 drugs studied
Area of expertise
1Brain Cancer
Stage IV
HER2 positive
ALK negative
2Brain Tumor
Stage IV
HER2 positive
ALK negative
Affiliated Hospitals
Clinical Trials Manmeet Ahluwalia, MD is currently running
Combination Therapy + SRS
for Brain Cancer from Breast Cancer
This research study will evaluate how well brain metastases associated with HER-2 positive breast cancer can be controlled using a type of radiation known as stereotactic radiosurgery (SRS) when combined with three therapeutic agents, tucatinib, capecitabine, and trastuzumab. The combined use of SRS with the three drugs is considered investigational.
Recruiting1 award Phase 115 criteria
Sigvotatug Vedotin vs Docetaxel
for Lung Cancer
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Recruiting2 awards Phase 35 criteria
More about Manmeet Ahluwalia, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Manmeet Ahluwalia, MD has experience with
- Capecitabine
- Stereotactic Radiosurgery
- Trastuzumab
- Tucatinib
- Exablate Model 4000 Type 2.0/2.1
- Pembrolizumab
Breakdown of trials Manmeet Ahluwalia, MD has run
Brain Cancer
Brain Tumor
Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manmeet Ahluwalia, MD specialize in?
Manmeet Ahluwalia, MD focuses on Brain Cancer and Brain Tumor. In particular, much of their work with Brain Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Manmeet Ahluwalia, MD currently recruiting for clinical trials?
Yes, Manmeet Ahluwalia, MD is currently recruiting for 4 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Manmeet Ahluwalia, MD has studied deeply?
Yes, Manmeet Ahluwalia, MD has studied treatments such as Capecitabine, Stereotactic Radiosurgery, Trastuzumab.
What is the best way to schedule an appointment with Manmeet Ahluwalia, MD?
Apply for one of the trials that Manmeet Ahluwalia, MD is conducting.
What is the office address of Manmeet Ahluwalia, MD?
The office of Manmeet Ahluwalia, MD is located at: Miami Cancer Institute at Baptist Health, Inc., Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute at Baptist Health, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.